CD8A and neoplasm: Both proteins correlated with tumor immune features, including increased tumor-infiltrating lymphocytes (TILs) and PD-L1 expression for LALBA, and elevated CD8<sup>+</sup> T cells, PD-L1, and TIM-3 expression for NCL.